|
1
|
American Cancer Society: Cancer Facts and
Figures 2011. Atlanta, GA: American Cancer Society; 2011,
www.cancer.org/Research/CancerFactsFigures/indexurisimplewww.cancer.org/Research/CancerFactsFigures/index.
Accessed July 27 2011.
|
|
2
|
Tortolina L, Castagnino N, De Ambrosi C,
Moran E, Patrone F, Ballestrero A and Parodi S: A multi-scale
approach to colorectal cancer: from a biochemical-interaction
signaling-network level, to multi-cellular dynamics of malignant
transformation. Interplay with mutations and onco-protein inhibitor
drugs. Curr Cancer Drug Targets. 12:339–355. 2012. View Article : Google Scholar
|
|
3
|
Minoo P, Zlobec I, Peterson M, Terracciano
L and Lugli A: Characterization of rectal, proximal and distal
colon cancers based on clinicopathological, molecular and protein
profiles. Int J Oncol. 37:707–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanwar SS, Poolla A and Majumdar AP:
Regulation of colon cancer recurrence and development of
therapeutic strategies. World J Gastrointest Pathophysiol. 3:1–9.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Siu KT, Rosner MR and Minella AC: An
integrated view of cyclin E function and regulation. Cell Cycle.
11:57–64. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Koff A, Cross F, Fisher A, Schumacher J,
Leguellec K, Philippe M and Roberts JM: Human cyclin E, a new
cyclin that interacts with two members of the CDC2 gene family.
Cell. 66:1217–1228. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Stamatakos M, Palla V, Karaiskos I,
Xiromeritis K, Alexiou I, Pateras I and Kontzoglou K: Cell cyclins:
triggering elements of cancer or not? World J Surg Oncol.
8:1112010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
MacLachlan TK, Sang N and Giordano A:
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications
in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr.
5:127–156. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Howard CM, Claudio PP, De Luca A, et al:
Inducible pRb2/p130 expression and growth-suppressive mechanisms:
evidence of a pRb2/p130, p27Kip1, and cyclin E negative feedback
regulatory loop. Cancer Res. 60:2737–2744. 2000.PubMed/NCBI
|
|
10
|
Salon C, Merdzhanova G, Brambilla C,
Brambilla E, Gazzeri S and Eymin B: E2F-1, Skp2 and cyclin E
oncoproteins are upregulated and directly correlated in high-grade
neuroendocrine lung tumors. Oncogene. 26:6927–6936. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Shaye A, Sahin A, Hao Q, Hunt K, Keyomarsi
K and Bedrosian I: Cyclin E deregulation is an early event in the
development of breast cancer. Breast Cancer Res Treat. 115:651–659.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Keyomarsi K, Tucker SL, Buchholz TA, et
al: Cyclin E and survival in patients with breast cancer. N Engl J
Med. 347:1566–1575. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bedrosian I, Lu KH, Verschraegen C and
Keyomarsi K: Cyclin E deregulation alters the biologic properties
of ovarian cancer cells. Oncogene. 23:2648–2657. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Tenderenda M: A study on the prognostic
value of cyclins D1 and E expression levels in resectable gastric
cancer and on some correlations between cyclins expression,
histoclinical parameters and selected protein products of
cell-cycle regulatory genes. J Exp Clin Cancer Res. 24:405–414.
2005.
|
|
15
|
Yasui W, Kuniyasu H, Yokozaki H, Semba S,
Shimamoto F and Tahara E: Expression of cyclin E in colorectal
adenomas and adenocarcinomas: correlation with expression of Ki-67
antigen and p53 protein. Virchows Arch. 429:13–19. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Griniatsos J, Michail OP, Theocharis S, et
al: Circadian variation in expression of G1 phase cyclins D1 and E
and cyclin-dependent kinase inhibitors p16 and p21 in human bowel
mucosa. World J Gastroenterol. 12:2109–2114. 2006.PubMed/NCBI
|
|
17
|
Corin I, Larsson L, Bergström J,
Gustavsson B and Derwinger K: A study of the expression of Cyclin E
and its isoforms in tumor and adjacent mucosa, correlated to
patient outcome in early colon cancer. Acta Oncol. 49:63–69. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Simone C, Resta N, Bagella L, Giordano A
and Guanti G: Cyclin E and chromosome instability in colorectal
cancer cell lines. Mol Pathol. 55:200–203. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zeestraten EC, Maak M, Shibayama M, et al:
Specific activity of cyclin-dependent kinase I is a new potential
predictor of tumour recurrence in stage II colon cancer. Br J
Cancer. 106:133–140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Steinberg SM, Barkin JS, Kaplan RS and
Stablein DM: Prognostic indicators of colon tumors. The
Gastrointestinal Tumor Study Group experience. Cancer.
57:1866–1870. 1986. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gunderson LL, Jessup JM, Sargent DJ,
Greene FL and Stewart AK: Revised TN categorization for colon
cancer based on national survival outcomes data. J Clin Oncol.
28:264–271. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Potemski P, Kusinska R, Watala C,
Pluciennik E, Bednarek AK and Kordek R: Prognostic relevance of
basal cytokeratin expression in operable breast cancer. Oncology.
69:478–485. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ioachim E: Expression patterns of cyclins
D1, E and cyclin-dependent kinase inhibitors p21waf1/cip1, p27kip1
in colorectal carcinoma: correlation with other cell cycle
regulators (pRb, p53 and Ki-67 and PCNA) and clinicopathological
features. Int J Clin Pract. 62:1736–1743. 2008. View Article : Google Scholar
|
|
24
|
Li JQ, Wu F, Masaki T, et al: Correlation
of Skp2 with carcinogenesis, invasion, metastasis, and prognosis in
colorectal tumors. Int J Oncol. 25:87–95. 2004.PubMed/NCBI
|
|
25
|
Donnellan R and Chetty R: Cyclin E in
human cancers. FASEB J. 13:773–780. 1999.PubMed/NCBI
|
|
26
|
Kitahara K, Yasui W, Kuniyasu H, et al:
Concurrent amplification of cyclin E and CDK2 genes in colorectal
carcinomas. Int J Cancer. 62:25–28. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhou YJ, Xie YT, Gu J, Yan L, Guan GX and
Liu X: Overexpression of cyclin E isoforms correlates with poor
prognosis in rectal cancer. Eur J Surg Oncol. 37:1078–1084. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Iwatsuki M, Mimori K, Ishii H, et al: Loss
of FBXW7, a cell cycle regulating gene, in colorectal cancer:
clinical significance. Int J Cancer. 126:1828–1837. 2010.PubMed/NCBI
|
|
29
|
Perea J, Alvaro E, Rodríguez Y, et al:
Approach to early-onset colorectal cancer: clinicopathological,
familial, molecular and immunohistochemical characteristics. World
J Gastroenterol. 16:3697–3703. 2010. View Article : Google Scholar
|
|
30
|
Sutter T, Dansranjavin T, Lubinski J,
Debniak T, Giannakudis J, Hoang-Vu C and Dralle H: Overexpression
of cyclin E protein is closely related to the mutator phenotype of
colorectal carcinoma. Int J Colorectal Dis. 17:374–380. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Lim YJ, Kim YH, Ahn GH, et al: Cyclin E,
p27 and mutant p53 do not predict the prognosis in AJCC stage II
colorectal carcinomas. Korean J Gastroenterol. 44:314–320.
2004.PubMed/NCBI
|
|
32
|
Li JQ, Miki H, Ohmori M, Wu F and Funamoto
Y: Expression of cyclin E and cyclin-dependent kinase 2 correlates
with metastasis and prognosis in colorectal carcinoma. Hum Pathol.
32:945–953. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang A, Yoshimi N, Suzui M, Yamauchi A,
Tarao M and Mori H: Different expression patterns of cyclins A, D1
and E in human colorectal cancer. J Cancer Res Clin Oncol.
122:122–126. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Bondi J, Husdal A, Bukholm G, Nesland JM,
Bakka A and Bukholm IR: Expression and gene amplification of
primary (A, B1, D1, D3, and E) and secondary (C and H) cyclins in
colon adenocarcinomas and correlation with patient outcome. J Clin
Pathol. 58:509–514. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Aamodt R, Jonsdottir K, Andersen SN, Bondi
J, Bukholm G and Bukholm IR: Differences in protein expression and
gene amplification of cyclins between colon and rectal
adenocarcinomas. Gastroenterol Res Pract. 2009:2858302009.
View Article : Google Scholar : PubMed/NCBI
|
